Results 191 to 200 of about 27,626 (220)

Scedosporium Apiospermum: A Rare Cause of Necrotizing Otitis Externa. Our Experience and A Review of the Current Literature. [PDF]

Indian J Otolaryngol Head Neck Surg
Chiavarini E, Cerritelli L, Caranti A, Ciorba A, Malagutti N, Borin M, Pelucchi S.   +6 more
europepmc   +1 more source

Safety and recommendation of voriconazole for invasive pulmonary aspergillosis in severe liver disease patients: a retrospective cohort study. [PDF]

BMC Infect Dis
Zhang X, Zheng C, Zhang L, Sun Y, Liang Y, Chen X, Pang L, Zhang Y.   +7 more
europepmc   +1 more source

Osteomyelitis Caused by <i>Moesziomyces aphidis</i> in an Immunocompetent Adult: A Case Report and Literature Review. [PDF]

Trop Med Infect Dis
Chen YY, Yeh TK, Wu CJ, Liu PY.
europepmc   +1 more source

The S862C amino acid change in CpMrr1 confers fluconazole resistance in <i>Candida parapsilosis</i>. [PDF]

JAC Antimicrob Resist
Franconi I, Poma N, Rizzato C, Maltinti L, Falcone M, Tavanti A, Lupetti A.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Voriconazole

Clinical Therapeutics, 2003
Reports of resistance and intolerance to currently available antifungal agents are increasing. Voriconazole is a broad-spectrum azole antifungal agent structurally derived from fluconazole. It is indicated for the treatment of invasive aspergillosis and serious fungal infections caused by Scedosporium apiospermum and Fusarium species in patients who ...
LilyAnn, Jeu, Frank J, Piacenti, Aleksandr G, Lyakhovetskiy, Horatio B, Fung   +3 more
openaire   +2 more sources

Pharmacoeconomics of voriconazole

Expert Opinion on Pharmacotherapy, 2010
The recent increase in the use of antineoplastic and immune suppressive agents and the use of broad-spectrum antibiotics, prosthetic interventions, organ transplants and more aggressive surgery have been related to a greater prevalence of invasive fungal infections (IFI).
Santiago Grau, C. Rubio-Terrés
openaire   +2 more sources

Voriconazole in clinical practice

Journal of Chemotherapy, 2012
Invasive fungal diseases are associated with significant morbidity and mortality in immunocompromized patients. Voriconazole is the first line treatment of invasive aspergillosis, and has been successfully used in other invasive fungal infections, such as candidiasis, fusariosis or scedosporidiosis.
MIKULSKA, MALGORZATA KAROLINA, Novelli A, Aversa F, Cesaro S, de Rosa FG, Girmenia C, Micozzi A, Sanguinetti M, VISCOLI, CLAUDIO   +8 more
openaire   +6 more sources

Voriconazole plasma monitoring

Archives of Disease in Childhood, 2008
Very little information is available regarding the use of voriconazole drug monitoring in children with invasive fungal infections. The purpose of this study was to report the cases of five paediatric patients treated with voriconazole, in which plasma levels were used to monitor therapy.Five children treated with voriconazole were included in this ...
Pasqualotto, A. C., Shah, M., Wynn, R., Denning, D. W.   +3 more
openaire   +4 more sources

Voriconazole‐induced pseudoporphyria

Photodermatology, Photoimmunology & Photomedicine, 2007
Pseudoporphyria is a bullous photosensitivity, the commonest aetiology being secondary to various ingested medications. Voriconazole is a relatively new second‐generation triazole antifungal agent. There have only been two reports of pseudoporphyria secondary to voriconazole. We report the third case of this phenomenon occurring in a lady being treated
Tolland, J.P., McKeown, Pascal, Corbett, J.R.   +2 more
openaire   +3 more sources

Voriconazole-Associated Myositis

JCR: Journal of Clinical Rheumatology, 2009
Voriconazole is a new triazole antifungal agent that is now the treatment of choice for invasive aspergillosis. Drug-induced myopathy has never previously been reported with voriconazole, although it is recognized with other triazole agents. We present a 34-year-old female African American renal transplant recipient, with a prior history of probable ...
Cal S. Matsumoto, Princy Kumar, Edward Pien, Virginia D. Steen, Sean Whelton, Jessica Rosen, Victoria K. Shanmugam   +6 more
openaire   +3 more sources